Omalizumab improves forced expiratory volume in 1 second in patients with severe asthma
Asthma is a multiphenotypic disease, and therapeutic management in patients with severe asthma is particularly difficult, with conventional treatment of severe asthma showing poor efficacy. The inclusion of omalizumab as adjunctive therapy improves asthma control. The studies conducted have shown th...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2018-07-01
|
| Series: | Advances in Dermatology and Allergology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Omalizumab-improves-forced-expiratory-volume-in-1-second-in-patients-with-severe-asthma,7,33349,1,1.html |